Global Markets for Blood Plasma Products

Report Highlights

The global blood plasma products market should reach $45.7 billion by 2027 from $33.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2022 to 2027.

Report Includes

• 44 data tables and 30 additional tables
• An overview of the global market for blood plasma products
• Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
• Characterization and quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
• Detailed information related to mode of delivery for blood plasma
• Analysis of key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
• Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
• In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
• A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centres and rising disease awareness and education
• Profiles of the major players in the industry, including ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.

Report Scope

This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.

The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. It also features an in-depth analysis of the key companies operating in the global blood plasma products market, and it surveys patents that highlight past, current and projected global technology trends. The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.

In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues.

A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches and pipeline products are provided.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.